Pulmonx Corp Stock Investor Sentiment

LUNG Stock  USD 7.52  0.47  6.67%   
Roughly 52% of Pulmonx Corp's investor base is interested to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are impartial at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
  

Pulmonx Corp Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at thelincolnianonline.com         
Analyzing Spectral Medical Pulmonx
news
six days ago at thelincolnianonline.com         
Pulmonx Co. Receives Average Recommendation of Moderate Buy from Brokerages
news
six days ago at benzinga.com         
This Pulmonx Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Monday
benzinga news
over a week ago at simplywall.st         
Have Pulmonx Insiders Been Selling Stock?
Simply Wall St News at Macroaxis
over a week ago at thelincolnianonline.com         
Pulmonx Co. Insider Geoffrey Beran Rose Sells 5,779 Shares
news
over a week ago at thelincolnianonline.com         
Disposition of 719 shares by David Lehman of Pulmonx Corp at 6.97 subject to Rule 16b-3
news
over a week ago at news.google.com         
Disposition of 2017 shares by Geoffrey Rose of Pulmonx Corp at 7.12 subject to Rule 16b-3
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Disposition of 2017 shares by Geoffrey Rose of Pulmonx Corp at 7.12 subject to Rule 16b-3
Yahoo News
over two weeks ago at news.google.com         
Pulmonx director French Glendon E. III sells shares worth 29,625 - MSN
Google News at Macroaxis
over two weeks ago at simplywall.st         
Pulmonx Full Year 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over three weeks ago at simplywall.st         
Pulmonx Corporation Just Reported Full-Year Earnings Have Analysts Changed Their Mind On The Stock?
Simply Wall St News at Macroaxis
over three weeks ago at finance.yahoo.com         
Pulmonx Full Year 2024 Earnings Beats Expectations
Yahoo News
over three weeks ago at finance.yahoo.com         
Pulmonx Corp Q4 2024 Earnings Call Highlights Strong Revenue Growth Amid Financial ...
Yahoo News
over three weeks ago at benzinga.com         
Disposition of 12417 shares by Glendon French of Pulmonx Corp at 8.76 subject to Rule 16b-3
benzinga news
over three weeks ago at insidermonkey.com         
Pulmonx Corporation Q4 2024 Earnings Call Transcript
insidermonkey News
Far too much social signal, news, headlines, and media speculation about Pulmonx Corp that are available to investors today. That information is available publicly through Pulmonx media outlets and privately through word of mouth or via Pulmonx internal channels. However, regardless of the origin, that massive amount of Pulmonx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulmonx Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmonx Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmonx Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmonx Corp alpha.

Pulmonx Corp Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3
12/23/2024
2
Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3
12/30/2024
3
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
01/17/2025
4
Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
02/05/2025
5
Pulmonx Co. Receives Consensus Rating of Moderate Buy from Analysts
02/13/2025
6
What To Expect From Pulmonx Corp Q4 2024 Earnings
02/19/2025
7
Pulmonx projects 16-18 percent constant currency growth for 2025 with key initiatives scaling
02/20/2025
8
Pulmonx Full Year 2024 Earnings Beats Expectations
02/28/2025
9
Disposition of 2017 shares by Geoffrey Rose of Pulmonx Corp at 7.12 subject to Rule 16b-3
03/05/2025
10
Have Pulmonx Insiders Been Selling Stock
03/07/2025
11
Analyzing Spectral Medical Pulmonx
03/11/2025

Complementary Tools for Pulmonx Stock analysis

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities